Search Results - "Raimondi, S"

Genetic relationships and introgression events between wild and cultivated grapevines (Vitis vinifera L.): focus on Italian Lambruscos by Schneider, A., Ruffa, P., Tumino, G., Fontana, M., Boccacci, P., Raimondi, S.

“…Research efforts on genomic structure and ecology of wild populations of Vitis vinifera L. offer insights on grape domestication processes and on the…”
Get full text

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia by Pui, C H, Pei, D, Sandlund, J T, Ribeiro, R C, Rubnitz, J E, Raimondi, S C, Onciu, M, Campana, D, Kun, L E, Jeha, S, Cheng, C, Howard, S C, Metzger, M L, Bhojwani, D, Downing, J R, Evans, W E, Relling, M V

“…We analyzed the long-term outcome of 1011 patients treated in five successive clinical trials (Total Therapy Studies 11, 12, 13A, 13B, and 14) between 1984 and…”
Get full text

Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy by Pui, C-H, Pei, D, Raimondi, S C, Coustan-Smith, E, Jeha, S, Cheng, C, Bowman, W P, Sandlund, J T, Ribeiro, R C, Rubnitz, J E, Inaba, H, Gruber, T A, Leung, W H, Yang, J J, Downing, J R, Evans, W E, Relling, M V, Campana, D

“…To determine the clinical significance of minimal residual disease (MRD) in patients with prognostically relevant subtypes of childhood acute lymphoblastic…”
Get full text

A revised definition for cure of childhood acute lymphoblastic leukemia by Pui, C H, Pei, D, Campana, D, Cheng, C, Sandlund, J T, Bowman, W P, Hudson, M M, Ribeiro, R C, Raimondi, S C, Jeha, S, Howard, S C, Bhojwani, D, Inaba, H, Rubnitz, J E, Metzger, M L, Gruber, T A, Coustan-Smith, E, Downing, J R, Leung, W H, Relling, M V, Evans, W E

“…With improved contemporary therapy, we reassess long-term outcome in patients completing treatment for childhood acute lymphoblastic leukemia (ALL) to…”
Get full text

Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome by Schwartz, J R, Wang, S, Ma, J, Lamprecht, T, Walsh, M, Song, G, Raimondi, S C, Wu, G, Walsh, M F, McGee, R B, Kesserwan, C, Nichols, K E, Cauff, B E, Ribeiro, R C, Wlodarski, M, Klco, J M

Get full text

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy by Bhojwani, D, Pei, D, Sandlund, J T, Jeha, S, Ribeiro, R C, Rubnitz, J E, Raimondi, S C, Shurtleff, S, Onciu, M, Cheng, C, Coustan-Smith, E, Bowman, W P, Howard, S C, Metzger, M L, Inaba, H, Leung, W, Evans, W E, Campana, D, Relling, M V, Pui, C-H

“…ETV6-RUNX1 fusion is the most common genetic aberration in childhood acute lymphoblastic leukemia (ALL). To evaluate whether outcomes for this drug-sensitive…”
Get full text

Impact of chlorpyrifos on human villous trophoblasts and chorionic villi by Ridano, M.E., Racca, A.C., Flores-Martin, J.B., Fretes, R., Bandeira, C.L., Reyna, L., Bevilacqua, E., Genti-Raimondi, S., Panzetta-Dutari, G.M.

“…Placental barrier regulates maternal-fetal interchange protecting the baby from damage caused by substances found in the uterine environment or circulating in…”
Get full text

The association between pesticide use and cutaneous melanoma: a systematic review and meta‐analysis by Stanganelli, I., De Felici, M.B., Mandel, V.D., Caini, S., Raimondi, S., Corso, F., Bellerba, F., Quaglino, P., Sanlorenzo, M., Ribero, S., Medri, M., Farnetani, F., Feliciani, C., Pellacani, G., Gandini, S.

“…Background The incidence of cutaneous melanoma (CM), the deadliest form of skin cancer, has gradually increased in the last decades among populations of…”
Get full text

Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1 by Jeha, S, Pei, D, Raimondi, S C, Onciu, M, Campana, D, Cheng, C, Sandlund, J T, Ribeiro, R C, Rubnitz, J E, Howard, S C, Downing, J R, Evans, W E, Relling, M V, Pui, C-H

“…To evaluate the impact of contemporary therapy on the clinical outcome of children with pre-B acute lymphoblastic leukemia (ALL) and the t(1;19)/ TCF3/PBX1 ,…”
Get full text

A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children’s Oncology Group by Eidenschink Brodersen, L, Alonzo, T A, Menssen, A J, Gerbing, R B, Pardo, L, Voigt, A P, Kahwash, S B, Hirsch, B, Raimondi, S, Gamis, A S, Meshinchi, S, Loken, M R

Get full text

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000 by Ravindranath, Y, Chang, M, Steuber, C P, Becton, D, Dahl, G, Civin, C, Camitta, B, Carroll, A, Raimondi, S C, Weinstein, H J

“…From 1981 to 2000, a total of 1823 children with acute myeloid leukemia (AML) enrolled on four consecutive Pediatric Oncology Group (POG) clinical trials. POG…”
Get full text

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23) by Lorsbach, R B, Moore, J, Mathew, S, Raimondi, S C, Mukatira, S T, Downing, J R

“…Leukemia (2003) 17, 637-641. doi:10.1038/sj.leu.2402834…”
Get full text

How many roads lead to stillbirth rate reduction? A 30-year analysis of risk factors in a Northern Italy University care center by Raimondi, S, Mascherpa, M, Ravaldi, C, Vannacci, A, Marconi, A M, Bulfamante, G P, Avagliano, L

“…Stillbirths affect more than 2.5 million pregnancies worldwide every year and the progress in reducing stillbirth rates is slower than that required by World…”
Get full text

Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients by Pellegrini, C., Raimondi, S., Di Nardo, L., Ghiorzo, P., Menin, C., Manganoni, M.A., Palmieri, G., Guida, G., Quaglino, P., Stanganelli, I., Massi, D., Pastorino, L., Elefanti, L., Tosti, G., Queirolo, P., Leva, A., Maurichi, A., Rodolfo, M., Fargnoli, M.C., Martinoli, Chiara, Gandini, Sara, Vecchiato, Antonella, Alaibac, Mauro, Facchetti, Fabio, Ferrari, Andrea, Frigerio, Simona, Valeri, Barbara, Guida, Stefania, Giudice, Giuseppe, Ribero, Simone, Astrua, Chiara, Mazzoni, Laura

“…Background A polygenic inheritance involving high, medium and low penetrance genes has been suggested for melanoma susceptibility in adults, but genetic…”
Get full text

Hyaluronan as drug carrier. The in vitro efficacy and selectivity of Hyaluronan–Doxorubicin complexes to affect the viability of overexpressing CD44 receptor cells by Battistini, F.D., Flores-Martin, J., Olivera, M.E., Genti-Raimondi, S., Manzo, R.H.

“…Schematic illustration of CD44-Hi-Dx complex. Mechanism implied in the enhanced internalization of Dx into cells. [Display omitted] We report Doxorubicin ionic…”
Get full text

IDH1 and IDH2 mutations in pediatric acute leukemia by Andersson, A K, Miller, D W, Lynch, J A, Lemoff, A S, Cai, Z, Pounds, S B, Radtke, I, Yan, B, Schuetz, J D, Rubnitz, J E, Ribeiro, R C, Raimondi, S C, Zhang, J, Mullighan, C G, Shurtleff, S A, Schulman, B A, Downing, J R

“…To investigate the frequency of isocitrate dehydrogenase 1 ( IDH1 ) and 2 ( IDH2 ) mutations in pediatric acute myeloid leukemia (AML) and acute lymphoid…”
Get full text

The organophosphate chlorpyrifos disturbs redox balance and triggers antioxidant defense mechanisms in JEG-3 cells by Chiapella, G, Flores-Martín, J, Ridano, M.E, Reyna, L, Magnarelli de Potas, G, Panzetta-Dutari, G.M, Genti-Raimondi, S

“…Abstract Introduction Reactive oxygen species (ROS) are produced by a number of physiological and pathological processes which influence the function of a…”
Get full text

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project by Tagliabue, Elena, Gandini, Sara, Bellocco, Rino, Maisonneuve, Patrick, Newton-Bishop, Julia, Polsky, David, Lazovich, DeAnn, Kanetsky, Peter A, Ghiorzo, Paola, Gruis, Nelleke A, Landi, Maria Teresa, Menin, Chiara, Fargnoli, Maria Concetta, García-Borrón, Jose Carlos, Han, Jiali, Little, Julian, Sera, Francesco, Raimondi, Sara

“…Melanoma represents an important public health problem, due to its high case-fatality rate. Identification of individuals at high risk would be of major…”
Get full text

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements by PUI, C-H, CHESSELLS, J. M, HARHOTT, J, HARMS, D. O, HARRISON, C. J, HARRISON, P. L, HEEREMA, N, JANKA-SCHAUB, G, KAMPS, W, MASERA, G, PULLEN, J, RAIMONDI, S. C, CAMITTA, B, RICHARDS, S, RIEHM, H, SALLAN, S, SATHER, H, SHUSTER, J, SILVERMAN, L. B, VALSECCHI, M. G, VILMER, E, ZHOU, Y, GAYNON, P. S, BARUCHEL, A, SCHRAPPE, M, BIONDI, A, BOYETT, J. M, CARROLL, A, EDEN, O. B, EVANS, W. E, GADNER, H

“…To assess the clinical heterogeneity among patients with acute lymphoblastic leukemia (ALL) and various 11q23 abnormalities, we analyzed data on 497 infants,…”
Get full text

MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M‐SKIP project by Stefanaki, I., Stratigos, A.J., Kypreou, K.P., Evangelou, E., Gandini, S., Maisonneuve, P., Polsky, D., Lazovich, D., Newton‐Bishop, J., Kanetsky, P.A., Puig, S., Gruis, N.A., Ghiorzo, P., Pellegrini, C., De Nicolo, A., Ribas, G., Guida, G., Garcia‐Borron, J.C., Fargnoli, M.C., Nan, H., Landi, M.T., Little, J., Sera, F., Raimondi, S.

Get full text